CN100386097C - Medicine with quantitative antiendotoxic action - Google Patents

Medicine with quantitative antiendotoxic action Download PDF

Info

Publication number
CN100386097C
CN100386097C CNB001077783A CN00107778A CN100386097C CN 100386097 C CN100386097 C CN 100386097C CN B001077783 A CNB001077783 A CN B001077783A CN 00107778 A CN00107778 A CN 00107778A CN 100386097 C CN100386097 C CN 100386097C
Authority
CN
China
Prior art keywords
chinese medicine
pure chinese
medicine preparation
radix
endotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB001077783A
Other languages
Chinese (zh)
Other versions
CN1325692A (en
Inventor
姜伟
陈丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenyang Feilong Pharmaceutical Co., Ltd.
Original Assignee
SHENYANG FEILONG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENYANG FEILONG PHARMACEUTICAL CO Ltd filed Critical SHENYANG FEILONG PHARMACEUTICAL CO Ltd
Priority to CNB001077783A priority Critical patent/CN100386097C/en
Publication of CN1325692A publication Critical patent/CN1325692A/en
Application granted granted Critical
Publication of CN100386097C publication Critical patent/CN100386097C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a pure Chinese medicine preparation which is a recipe of medicine with quantitative antiendotoxic action; 2727g of honeysuckle, 2727g of forsythia, 1364g of scutellaria, 11.36g of sodium decanoyl acetaldehyde, 1636g of red peony and 909g of rhubarb are made into a capsule. The present invention has the advantages of reasonable prescription and obvious therapeutic effects. The pure Chinese medicine preparation is a pure green packing plant preparation and has the advantages of small side effects, safety, reliability and techniques purification technology. Proved by an experiment, the pure Chinese medicine preparation has specific active components. The pure Chinese medicine preparation has the action mechanism of directly eliminating endotoxin and is breakthrough contribution to medicine history. The pure Chinese medicine preparation acts on the middle link of an inflammation reaction, takes effect quickly, avoids serious complicating diseases such as shock, DIC, MSOF, etc., induced by the increase of the endotoxin, and eliminates the effect of the endotoxin. The pure Chinese medicine preparation is verified by a scientific test method. The pure Chinese medicine preparation does not have medicine resistance performance and is non hormone medicine. The present invention adjusts the immunological function of an organism and enhances antiendotoxic sterilization efficacy.

Description

A kind of medicine with anti-endotoxin effect
Technical field
The present invention relates to a kind of Chinese medicine preparation, be used to remove toxins in human body.
Background technology
The tradition antibiotic be with kill or suppress pathogenic microorganism, eliminate the inflammation is its mechanism of action, often causes the release of bacterial endotoxin sample material to increase in this process.
Summary of the invention
Purpose of the present invention discloses a kind of medicine with anti-endotoxin effect, and reasonable recipe is evident in efficacy.
The invention provides a kind of medicine, make capsule by crude drug Flos Lonicerae 2727g, Fructus Forsythiae 2727g, Radix Scutellariae 1346g, Sodium Houttuyfonate 11.36g, Radix Paeoniae Rubra 1636g, Radix Et Rhizoma Rhei 909g with anti-endotoxin effect.
The invention provides a kind of medicine with anti-endotoxin effect, its preparation technology is: Flos Lonicerae, Fructus Forsythiae, Radix Paeoniae Rubra, Radix Scutellariae are decocted with water three times, and 1.5 hours for the first time, second and third time respectively was 1 hour, and collecting decoction filters; Radix Et Rhizoma Rhei adds boiling water to be fried in shallow oil three times, and each 10 minutes, merge three times decocting liquid, filter; Merge above filtrate, fine straining, filtrate is adsorbed through adsorbent resin, and 70% ethanol elution, eluent are concentrated into proportion 1.15, and spray drying adds the Sodium Houttuyfonate fine powder, mixing, dry-pressing is granulated, and packs 1000 capsules into promptly.
Good effect of the present invention: reasonable recipe, evident in efficacy.
Toxic and side effects is little, and is safe and reliable;
Directly eliminating endotoxin is its mechanism of action;
Act on intermediate link, the onset rapidly of inflammatory reaction;
Can avoid because of endotoxic shock, the severe complications such as DIC, MSOF that bring out that increase;
Eliminating endotoxic effect can be verified through the scientific experiments method;
Adjust body's immunity, improve antibiotic bactericidal potency.
Description of drawings
Fig. 1 is a process chart of the present invention
The specific embodiment
Embodiment
Flos Lonicerae 2727g, Fructus Forsythiae 2727g, Radix Scutellariae 1346g, Sodium Houttuyfonate 11.36g, Radix Paeoniae Rubra 1636g, Radix Et Rhizoma Rhei 909g make capsule.
Flos Lonicerae, Fructus Forsythiae, Radix Paeoniae Rubra, Radix Scutellariae are decocted with water three times, and 1.5 hours for the first time, second and third time respectively was 1 hour, and collecting decoction filters; Radix Et Rhizoma Rhei adds boiling water to be fried in shallow oil three times, and each 10 minutes, merge three times decocting liquid, filter; Merge above filtrate, fine straining, filtrate is adsorbed through adsorbent resin, and 70% ethanol elution, eluent are concentrated into proportion 1.15, and spray drying adds the Sodium Houttuyfonate fine powder, mixing, dry-pressing is granulated, and packs 1000 capsules into promptly.
Creativeness of the present invention is verified by clinical

Claims (2)

1. the medicine with anti-endotoxin effect is characterized in that: make capsule by crude drug Flos Lonicerae 2727g, Fructus Forsythiae 2727g, Radix Scutellariae 1346g, Sodium Houttuyfonate 11.36g, Radix Paeoniae Rubra 1636g, Radix Et Rhizoma Rhei 909g.
2. according to the described medicine with anti-endotoxin effect of claim 1, it is characterized in that: preparation technology is: Flos Lonicerae, Fructus Forsythiae, Radix Paeoniae Rubra, Radix Scutellariae are decocted with water three times, and 1.5 hours for the first time, second and third time respectively was 1 hour, and collecting decoction filters; Radix Et Rhizoma Rhei adds boiling water to be fried in shallow oil three times, and each 10 minutes, merge three times decocting liquid, filter; Merge above filtrate, fine straining, filtrate is adsorbed through adsorbent resin, and 70% ethanol elution, eluent are concentrated into proportion 1.15, and spray drying adds the Sodium Houttuyfonate fine powder, mixing, dry-pressing is granulated, and packs 1000 capsules into promptly.
CNB001077783A 2000-05-26 2000-05-26 Medicine with quantitative antiendotoxic action Expired - Lifetime CN100386097C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001077783A CN100386097C (en) 2000-05-26 2000-05-26 Medicine with quantitative antiendotoxic action

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001077783A CN100386097C (en) 2000-05-26 2000-05-26 Medicine with quantitative antiendotoxic action

Publications (2)

Publication Number Publication Date
CN1325692A CN1325692A (en) 2001-12-12
CN100386097C true CN100386097C (en) 2008-05-07

Family

ID=4578935

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001077783A Expired - Lifetime CN100386097C (en) 2000-05-26 2000-05-26 Medicine with quantitative antiendotoxic action

Country Status (1)

Country Link
CN (1) CN100386097C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1954818B (en) * 2005-10-25 2010-04-28 崔乃杰 Application of phillyrin in preparation for treating endotoxemia
CN103893290A (en) * 2012-12-28 2014-07-02 四川省中医药科学院 Pharmaceutical composition of endotoxin antagonist and preparation method thereof
CN110522880A (en) * 2018-05-24 2019-12-03 河南炎黄生物工程有限公司 A kind of Chinese medicine composition for preventing and treating laying hen mycotoxicosis, Chinese medicine microecological preparation and preparation method thereof

Also Published As

Publication number Publication date
CN1325692A (en) 2001-12-12

Similar Documents

Publication Publication Date Title
CN113521232B (en) A Chinese medicinal composition containing Atractylodis rhizoma
CN100386097C (en) Medicine with quantitative antiendotoxic action
Jakeli et al. Biodiversity of Medicinal Plants of wild flora in Ajara-South Colchis and their usage in folk medicine
CN110693997A (en) Preparation for removing putrefaction and promoting granulation of scald and burn and preparation method thereof
CN101983689B (en) Drug for treating prostatitis and preparation method thereof
CN101485701B (en) Method for preparing total polyphenol of Loropetalum chinense (R. Br.) Oliver for treating burn and scald
CN102293819B (en) Tea saponin vagina-protecting lotion
CN1227022C (en) Capsule for treating epidemic parotitis
CN101391044A (en) External traditional Chinese medicine for treating zoster, herpes simplex or the other viral disease and preparation method thereof
CN101987159B (en) Medicine for treating erysipelas and preparation method thereof
CN102309626A (en) Traditional Chinese medicine prescription for treating postpartum fever
CN102895386B (en) Method for performing extraction on angelica dahurica, common cnidium fruit, Chinese red pepper and elecampane inula root and pharmaceutical application
CN100418551C (en) Ready prepared chinese medicine 'erjingling' drops for treating tympanitis and its preparation method
CN109078115A (en) A kind of Chinese materia medica preparation and preparation method thereof for hemorrhage of digestive tract
CN1164318C (en) Capsule for treating gynaecological inflammation
CN103610928B (en) A kind of Chinese medicine for the treatment of anaphy lactoid purpura nephritis
CN101972388B (en) Extraction method of smilax glabra total glycoside extractive
CN100446786C (en) Technique for producing extract product of mulberry bark
CN105147821A (en) Traditional Chinese medicine composition used for regulating endocrine function and preparation method
CN1194732C (en) Chinese herbal medicine for treating coronary heart disease and angina pectoris and its prepn
CN101322784B (en) Medicament with stomach-regulating and antidiarrheal efficacy and producing method thereof
CN101147792B (en) Method for preparing capsule for treating hepatitis B, clearing heat and antitoxic
CN113440546A (en) Acanthopanax senticosus total saponin, extraction method and application
CN104147211A (en) Medicine for treating gynecologic inflammation
CN1486723A (en) Menoxenia treating Chinese medicine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: SHENYANG FEILONG PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: JIANG WEI

Effective date: 20060224

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20060224

Address after: 110166, 25, Changbai street, Heping District, Liaoning, Shenyang

Applicant after: Shenyang Feilong Pharmaceutical Co., Ltd.

Address before: 110166, 25, Changbai street, Heping District, Liaoning, Shenyang

Applicant before: Jiang Wei

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: JIANG WEI

Free format text: FORMER OWNER: SHENYANG FEILONG PHARMACEUTICAL CO., LTD.

Effective date: 20080523

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20080523

Address after: Hunnan New District in Shenyang city of Liaoning Province Road No. 9, block A 203

Patentee after: Jiang Wei

Address before: Hunnan New District in Shenyang city of Liaoning Province Road No. 9, block A 203

Patentee before: Shenyang Feilong Pharmaceutical Co., Ltd.

ASS Succession or assignment of patent right

Owner name: SHENYANG FEILONG PHARMACEUTICAL CO., LTD.

Free format text: FORMER OWNER: JIANG WEI

Effective date: 20140207

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 110179 SHENYANG, LIAONING PROVINCE TO: 110300 SHENYANG, LIAONING PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140207

Address after: 110300 Xinmin Industrial Zone, Liaoning

Patentee after: Shenyang Feilong Pharmaceutical Co., Ltd.

Address before: Hunnan New District Road Shenyang city Liaoning province 110179 No. 9 A block 203

Patentee before: Jiang Wei

TR01 Transfer of patent right
CX01 Expiry of patent term

Granted publication date: 20080507

CX01 Expiry of patent term